
San Jorge debuts the technique of intraoperative radiotherapy
16 May 2019Aid for research and training in childhood cancer Aragón _ ASPANOA
17 May 2019Launch a new call and there will now be three lines of work open. The association's investment amounts to 320.000 euros, with 120.00 already executed
Aspanoa has done it again. In its tireless desire to help in the fight against childhood cancer, the Association of Parents of Children with Cancer of Aragón has just launched a new call to finance research projects related to this pathology in the community.
This is a line of work endowed with 60.000 euros and in which interested parties can present their proposals until next July 15, according to the association. The decision of the researcher or group that will win this investment will be made public by the Aspanoa Scientific Committee on September 15 of this year.
The rules of the call can be consulted on the group's own website, where they have been recently published.
The announcement of this new investment will become, when it has an assigned recipient, the third ongoing childhood cancer project in Aragon thanks to funding from Aspanoa. In this way, the committed contribution of the association in research on this disease now amounts to 320.000 euros, of which 120.000 have already been executed.
While interested parties present their proposals, progress continues in the other two open jobs. On the one hand, through the scientist Alberto Jiménez Schuhmacher, from the Health Research Institute (IIS) of Aragón, winner of last year's call, also worth 60.000 euros. He, along with his team, is working on finding new ways to diagnose diffuse trunk glioma (DIPG), a rare childhood brain tumor with a poor prognosis and which is currently practically impossible to biopsy.
On the other hand, Aspanoa contributed a total of 200.000 euros last year to launch, together with the DGA (which financed 100.000 euros), research that seeks more effective treatments against leukemias and neuroblastoma. These are the 40% of the most common childhood cancers.




